MARC Record from marc_columbia

LEADER: 06006cam a22003734a 4500
001 7093896
005 20221130205737.0
008 081016t20092009pauaf b 001 0 eng
010 $a 2008043233
016 7 $a101486800$2DNLM
019 $a255898194
020 $a9781416049289
020 $a1416049282
029 1 $aNLM$b101486800
035 $a(OCoLC)ocn263294887
035 $a(OCoLC)263294887$z(OCoLC)255898194
035 $a(NNC)7093896
035 $a7093896
040 $aDNLM/DLC$cDLC$dBTCTA$dNLM$dYDXCP$dC#P$dCDX$dOrLoB-B
042 $apcc
050 00 $aRC935.S64$bB68 2009
060 10 $aQV 140$bB751 2009
082 00 $a615/.329364$222
245 00 $aBotulinum toxin :$btherapeutic clinical practice and science /$cJoseph Jankovic, chief editor ; Alberto Albanese [and others].
260 $aPhiladelphia, PA :$bSaunders/Elsevier,$c[2009], ©2009.
300 $axv, 493 pages, 16 pages of plates :$billustrations (some color) ;$c27 cm
336 $atext$btxt$2rdacontent
337 $aunmediated$bn$2rdamedia
504 $aIncludes bibliographical references and index.
505 00 $g1.$tMultiple Steps in the Blockade of Exocytosis by Botulinum Neurotoxins /$rOliver Dolly, Jianghui Meng, Jiafu Wang, Gary W. Lawrence, MacDara Bodeker, Tomas H. Zurawski and Astrid Sasse -- $g2.$tMolecular Structures and Functional Relationships of Botulinum Neurotoxins /$rSubramanyam Swaminathan -- $g3.$tBotulinum Neurotoxin-a Modular Nanomachine /$rAudrey Fischer, Lilia Koriazova, Myrta Oblatt-Montal and Mauricio Montal -- $g4.$tInteractions Between Botulinum Neurotoxins and Synaptic Vesicle Proteins /$rAxel T. Brunger, Rongsheng Jin and Mark A. Breidenbach -- $g5.$tImmune Recognition of Botulinum Neurotoxins A and B: Molecular Elucidation of Immune Protection Against the Toxins /$rM. Zouhair Atassi and K. Roger Aoki -- $g6.$tBiology and Clinical Pharmacology of Botulinum Neurotoxin Type C and Other Non-A/ Non-B Botulinum Neurotoxins /$rRoberto Eleopra, Valeria Tugnoli and Cesare Montecucco -- $g7.$tEffects of Botulinum Toxin on Central Nervous System Function /$rCarlo Trompetto, Giovanni Abbruzzese, Antonio Suppa and Alfredo Berardelli -- $g8.$tBotulinum Neurotoxin Treatment of Cranial-Cervical Dystonia /$rChristopher Kenney and Joseph Jankovic -- $g9.$tBotulinum Neurotoxin Treatment of Limb and Occupational Dystonias /$rBarbara lllowsky Karp -- $g10.$tBotulinum Neurotoxin in Tremors, Tics, Hemifacial Spasm, Spasmodic Dysphonia, Stuttering /$rAnna Rita Bentivoglio, Alfonso Fasano and Alberto Albanese -- $g11.$tUpper Limb Skin and Musculoskeletal Consequences of the Upper Motor Neuron Syndrome /$rNathaniel H. Mayer and Alberto Esquenazi -- $g12.$tClinical Trials of Botulinum Toxin in Adult Spasticity /$rAntonio Elia, Filippini Graziella and Alberto Albanese -- $g13.$tBiological and Mechanical Pathologies in Spastic Skeletal Muscle: The Functional Implications of Therapeutic Neurotoxins /$rSamuel R. Ward and Richard L. Lieber -- $g14.$tTreatment of Motor Disorders in Cerebral Palsy with Botulinum Neurotoxin /$rJane Leonard and H. Kerr Graham -- $g15.$tClinical Experience and Recent Advances in the Management of Gait Disorders with Botulinum Neurotoxin /$rAlberto Esquenazi and Nathaniel H. Mayer -- $g16.$tTreatment of Oromandibular Dystonia, Bruxism, Temporomandibular Disorders with Botulinum Toxin /$rNwanmegha Young and Andrew Blitzer -- $g17.$tBotulinum Toxin in Headache Management /$rStephen D. Silberstein -- $g18.$tBotulinum Toxin Therapy in Gastrointestinal Disorders /$rRajasekhara Mummadi and Pankaj J. Pasricha -- $g19.$tMechanism of Action of Botulinum Neurotoxin in the Lower Urinary Tract /$rMichael B. Chancellor, George T. Somogyi and Christopher P. Smith -- $g20.$tBotulinum Toxin in Overactive Bladder /$rBrigitte Schurch and Dennis Dykstra -- $g21.$tBotulinum Toxin in the Treatment of Chronic Pelvic Pain Syndromes /$rPhillip P. Smith and Christopher P. Smith -- $g22.$tApplication of Botulinum Toxin in the Prostate /$rYao-Chi Chuang and Michael B. Chancellor -- $g23.$tClinical Application of Botulinum Neurotoxin in the Treatment of Myofascial Pain Syndromes /$rMartin K. Childers -- $g24.$tBotulinum Toxin for Osteoarticular Pain /$rMaren Lawson Mahowald, Hollis E. Krug, Jasvinder A. Singh and Dennis Dykstra -- $g25.$tBotulinum Neurotoxin in the Management of Hyperhidrosis and Other Hypersecretory Disorders /$rDee Anna Glaser and Markus Naumann -- $g26.$tBotulinum Neurotoxin for Dermatologic and Cosmetic Disorders /$rDee Anna Glaser -- $g27.$tThe Role of Botulinum Toxin in Wound Healing /$rHolger G. Gassner, David A. Sherris, Kris S. Moe and Oren Friedman -- $g28.$tUnderstanding Botulinum Neurotoxin Mechanism of Action and Structure to Enhance Therapeutics and Improve Care /$rKeith A. Foster, Emily J. Adams and Duncan F. Rogers -- $g29.$tUnmet Needs and Challenges in the Therapeutic Use of Botulinum Neurotoxins /$rDavid M. Simpson and Yuen T. So -- $g30.$tPotential New Therapeutic Indications for Botulinum Neurotoxins /$rMark Hallett -- $g31.$tBotulism Vaccines and the Immune Response /$rLeonard A. Smith and Janice M. Rusnak -- $g32.$tProperties of Pharmaceutical Products of Botulinum Neurotoxins /$rHans Bigalke -- $g33.$tComparative Clinical Trials of Botulinum Toxins /$rDirk Dressier and Cynthia L. Comella -- $g34.$tTetanus Toxin /$rPaul S. Fishman -- $g35.$tBungarotoxins /$rFlorenta Aura Kullmann, William Chet de Groat and Debra Elaine Artim -- $g36.$tBiology and Pharmacology of Conotoxins /$rRussell W. Teichert, Elsie C. Jimenez and Baldomero M. Olivera -- $g37.$tTherapeutic Applications of Conotoxins /$rMichael F. Saulino -- $g38.$tSpider and Wasp Neurotoxins /$rWagner Ferreira dos Santos.
650 0 $aBotulinum toxin$xTherapeutic use.$0http://id.loc.gov/authorities/subjects/sh2009117483
650 12 $aBotulinum Toxins$xtherapeutic use.$0https://id.nlm.nih.gov/mesh/D001905Q000627
700 1 $aJankovic, Joseph.$0http://id.loc.gov/authorities/names/n84176324
852 00 $boff,hsl$hRC935.S64$iB68 2009